Baird Is a Buyer of BioMarin (BMRN) On Genzyme-Related Weakness
Tweet Send to a Friend
Baird said they are buyers of BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) on weakness tied to Genzyme ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
